A putative yeast sn-2 acyltransferase gene (SLC7-7), reportedly a variant acyltransferase that suppresses a genetic defect in sphingolipid long-chain base biosynthesis, has been expressed in a yeast SLC deletion strain. The SLC7-7 gene product was shown in vitro to encode an sn-2 acyltransferase capable of acylating sn-1 oleoyl-lysophosphatidic acid, using a range of acyl-COA thioesters, including 181-, 22:l-, and 240-COAS. The SLC7-7 gene was introduced into Arabidopsis and a high erucic acid-containing Brassica napus cv Hero under the control of a constitutive (tandem cauliflower mosaic virus 35s) promoter. The resulting transgenic plants showed substantial increases of 8 to 48% in seed oil content (expressed on the basis of seed dry weight) and increases in both overall proportions and amounts of very-long-chain fatty acids in seed triacylglycerols (TAGs). Furthermore, the proportion of very-long-chain fatty acids found at the sn-2 position of TAGs was increased, and homogenates prepared from developing seeds of transformed plants exhibited elevated lysophosphatidic acid acyltransferase (EC 2.3.1 51) activity. Thus, the yeast sn-2 acyltransferase has been shown to encode a protein that can exhibit lysophosphatidic acid acyltransferase activity and that can be used to change total fatty acid content and composition as well as to alter the stereospecific acyl distribution of fatty acids in seed TAGS.
INTRODUCTION
There is interest in modifying seed oil fatty acid composition and content by molecular genetic means to provide a source of super high erucic acid rapeseed oil for use as an industrial feedstock (Taylor et al., 1993) . A similar interest exists for producing other strategic nonedible oils (e.g., seed oils high in hydroxy, epoxy, and short-and medium-chain fatty acids) in traditional oilseed crops (Murphy et al., 1994; MacKenzie, 1995) .
There are no published demonstrations of increases in oil content by transgenic approaches, although yield increases by traditional breeding and selection continue to bring about incremental improvements. In contrast, increases in the proportions of some strategic fatty acids have been achieved by the introduction or modulated expression of various plant fatty acid biosynthesis genes in oilseeds (Knutzon et al., 1992; Voelker et al., 1992 Voelker et al., , 1996 Hitz et al., 1995; Lassner et al., 1996) . In addition, the use of plant acyltransferase transgenes from Limnanfhes spp has resulted in altered seed oil ' To whom correspondence should be addressed. E-mail dtaylor@ pbi.nrc.ca; fax 306-975-4839. proportions of sn-2 erucic acid in rapeseed (Lassner et al., 1995; Brough et al., 1996) . However, the overall proportions of 22:l in the seed oil did not increase, and there was no report of increased total fatty acid or increased oil content.
There is little understanding of how the Kennedy pathway is regulated in oilseeds. Recently, we demonstrated that an Arabidopsis seed mutant, which accumulated lower amounts of triacylglycerols (TAGs) than did the wild type and had dramatically altered fatty acid composition, also exhibited reduced diacylglycerol acyltransferase activity (Katavic et al., 1995) . However, it is clear that additional studies are necessary before we can achieve directed increases in seed oil content and changes in TAG composition in oilseed plants.
The SLC7 (for Zphingojipid compensation) gene was cloned originally from a yeast (Saccharomyces cerevisiae) mutant lacking the ability to make sphingolipids . The suppressor allele, designated SLC7-7 (in which nucleotide 131 is a T residue rather than an A residue, resulting in amino acid 44 being a leucine rather than a glutamine), encodes a protein that suppresses the genetic defect in sphingolipid long-chain base biosynthesis (Nagiec et al., 1993) . Preliminary analyses of the SLC7-7 mutant, which was capable of normal growth without the need to supply a long-chain base, indicated that it was able to synthesize nove1 phosphatidylinositols having long-chain saturated fatty acyl groups in the sn-2 position. The working hypothesis has been that the SLC7-7 suppressor allele encodes an acyltransferase with an altered substrate specificity, enabling it to use a very-long-chain fatty acid (VLCFA; 26:O) to acylate the sn-2 position of inositol-containing glycerolipids (Nagiec et al., 1993) . The SLC7 sequence is somewhat similar (27% amino acid identity) to the Escherichia coli PLSC gene, which has been claimed to encode a lysophosphatidic acid acyltransferase (LPAT; EC 2.3.1 51) (Coleman, 1990 (Coleman, , 1992 . The SLCl gene complemented the growth defect in JC201 (a temperature-sensitive E. coli strain mutated in PLSC). Based on these findings, it was reported that SLC7 encodes a yeast sn-2 acyltransferase. However, the authors were unable to detect LPAT activity in the complemented E.
coli JC201 mutant (Nagiec et al., 1993) . To date, no conclusive evidence of the activity encoded by SLC7-7 or SLCl has been reported.
Based on our interest in modifying the VLCFA content of Brassicaceae (Taylor et al., 1993) , we have performed yeast transformation studies to determine the nature of the SLC7-7 gene product. We have also expressed the SLC7-7 suppressor allele gene in the model oilseed Arabidopsis and in a high erucic acid cultivar of Brassica napus. We repor3 that the yeast SLC7-7 gene product is indeed an sn-2 acyltransferase that can enhance seed LPAT activity and alter the oil content and oil composition of plant seed lipids.
R ESU LTS

Analysis of the SLCl-1 Gene Product
To confirm the function of SLC genes, we have cloned SLC7-7 and SLC7 encoding regions under the control of the Gal7 promoter in the yeast expression vector pYEUra3. The yeast strain YMN5, an SLCl null mutant, was used for the overexpression of SLC genes. As shown in Table 1 , after a 6-hr galactose induction period, lysates of both the SLCl and SLC7-7 transformants of YMN5 exhibited 18:l-CoA:LPAT activity, which was several-fold higher than the basal LPAT activity residing in the native YMN5 strain and/or YMN5 strain transformed with pYEUra3 only. In addition, both the SLC7-7 and SLCl gene products displayed LPAT activities with 22:l-COA and 24:0-CoA, whereas neither YMN5 transformed with pYEUra3 only (Table 1) nor nontransformed YMN5 (data not shown) was capable of using these verylong-chain acyl-CoAs. Furthermore, the SLC7-7 gene product appeared to have a higher relative activity with the verylong-chain acyl-COA donors (22:l -COA and 24:O-COA) than did the corresponding SLCl gene product; the longer the chain length of the fatty acyl moiety, the greater the difference in relative enzyme activity.
The trends in relative LPAT activity were consistent for two different induction periods (6 or 24 hr). In the SLC7-7 YMN5 transformant, the relative LPAT activity in the presence of 22:l-COA and 24:O-COA was -23 to 26% and 0.5 to 1.1 %, respectively, of the activity observed when 18:l -COA was supplied (Table 1) . The SLC7 YMN5 transformant exhibited LPAT activities of only 9 to 15% and 0.1 to 0.2% in the presente of 22:l -COA and 24:0-CoA, respectively, compared with that observed in the presence of 18:l-COA. Similar trends were observed in experiments in which another SLC deletion strain (YMN6-2C; slc7 A7 ::URA3 leu2) was transformed with YEp351 (a multicopy vector with an LEU2 marker; this was also supplied by M.M. Nagiec and R.C. Dickson, University of Kentucky, Lexington) containing either an SLCl or SLC7-7 gene insert (data not shown). Our results suggest that SLCl and SLC7-7 encode yeast sn-2 acyltransferases and are in good agreement with the previous suggestion (Nagiec et al., 1993) that the point mutation in the SLC7-7 gene results in a change in substrate specificity.
Because it had been suggested that the SLC7-7 suppressor allele gene product may be capable of acylating the sn-2 position of inositol-containing glycerolipids with G6 fatty acids aValues within parentheses represent +SD for which at least three determinations were performed. Nagiec et al., 1993) , we decided to test the capacity of the SLC genes to express nove1 sn-2 acyltransferase activities when supplied with lysophospholipids other than lysophosphatidic acid (LPA). Lysates of the YMN5 strain, or YMN5 transformed with pYEUra3 only, appeared to exhibit a basal capacity to produce I4C-l 8:l-radiolabeled phosphatidylinositol (Pl), phosphatidylcholine (PC), and phosphatidylethanolamine (PE) when sn-1 acyl lysophosphatidylinositol (LPI), sn-1 acyl lysophosphatidylcholine (LPC), or sn-1 acyl lysophosphatidylethanolamine (LPE) were supplied in the presence of I4C-labeled 18:l -COA. These activities depended on the addition of exogenous acceptor and were always at least 1 O-fold higher than control reactions (without exogenous lysophospholipid). Lysates of the YMN5 transformants containing the SLCl and SLC7-7 genes exhibited 1 O to 20% increases in these apparent activities. However, in all cases, the level of radiolabeled PI, PC, or PE observed was always two to three times lower than the level of radiolabeled phosphatidic acid (PA) produced in the corresponding LPAT reaction. Because these conversions were measured in cell-free lysates, it is possible that the observed activities could be artifacts arising from phospholipase D acting on the exogenous LPC, LPE, or LPI, converting these to LPA, which could then in turn act as a substrate in an LPAT reaction. Indeed, the reaction mixtures in which LPI was supplied always produced low levels of radiolabeled PA, which were approximately twofold higher than in the control reactions (without LPI). To observe this LPAT activity, the radiolabeled products were separated by thin-layer chromatography in a solvent system that resolved radiolabeled PA. Furthermore, neither the SLC7-7 nor the SLCl gene products were able to produce appreciable radiolabeled PI when lysates were incubated in the presence of sn-1 acyl LPI and either 14C-labeled 22:l-COA or 24:O-COA. Hence, it is unlikely that the SLC genes encode LPI-, LPC-, or LPE-specific acyltransferases, although we cannot rule out the possibility that the SLC gene products can use various lysophospholipids, if available in vivo. With this information, and our interest in modifying seed VLCFA content, we chose to conduct our plant transformation experiments using the mutated SLC7-7 gene encoding an sn-2 acyltransferase able to insert VLCFAs.
Generation and Molecular Characterization of Arabidopsis and 6. napus SLC7-7 Transgenic Plants
We constructed a plant transformation vector (pSLC7-7/ pRD400) with the SLC7-7 gene under the control of a tandem cauliflower mosaic virus 35s promoter (Datla et al., 1993) . We reasoned that with a constitutive promoter, the effect of the SLC7-7 gene, if any, could be investigated in developing seeds as well as in vegetative tissues.
Transformation of Arabidopsis (ecotype Columbia) was performed by wound inoculation (Katavic et al., 1994) or vacuum infiltration (Bechtold et al., 1993) DeBlock et al. (1989) , producing 10 transgenic lines. The presence of the SLC7-7 gene in kanamycin-resistant transformants was verified by polymerase chain reaction (PCR) and by DNA gel blot hybridization analyses (Southern, 1975 Gel blot hybridization analyses of RNA isolated from Arabidopsis T3 seeds at middevelopment confirmed the expression of the SLC7-7 gene in all lines tested. As shown in Figure  1 , the highest level of transcript among T, seeds was observed in lines 42-1 and 42-4. Similar analyses confirmed the presence of the SLC7-7 transcript in developing B. napus T3 seed (data not shown). There was no detectable signa1 after RNA gel blot analyses of developing seed from nontransformed Arabidopsis (Figure 1) or B. napus (data not shown). different in seed from the nontransformed wild type and from pBI121 or pRD400 control transformants (both without SLC1-1 insert). Within the total lipid extract, the proportions of polyunsaturated C 18 fatty acids in nontransformed wildtype controls and in pBI121 and pRD400 control transformants were 46.4 ± 2.3, 46.1 ± 2.3, and 43.5 ± 1.0 weight %, respectively, and the corresponding proportions of VLCFAs were also not significantly different (Table 3) . Those SLC1-1 T 2 transformants showing the greatest increases in seed oil and VLCFA content were selected, and individual seeds were planted to give T 3 progeny lines. To maintain valid comparisons within each experiment or generation, nontransformed control plants or control transformants (e.g., pBI121) were always grown in the same growth chamber at the same time as the SLC1-1 transformants. As shown in Figure 2 , analyses of T 3 seed from several independent SLC1-1 lines indicated that total lipid content (expressed as micrograms of fatty acids per 100 seeds) was increased by 35 to 110% compared with pBI121 control T 3 seed, and this was correlated with increased TAG content in the SLC1-1 transgenic plants (data not shown). These trends were equally valid when the oil content was expressed on a dry weight basis. The oil content of pBI121 control T 3 seeds (n = 5 plants) was 31.8 ± 1.1 % dry weight, similar to previous studies with nontransformed Arabidopsis ecotype Columbia (Taylor et al., 1995a) . The oil contents (on a dry weight basis) of T 3 seeds of SLC1-1 transgenic lines 16-5, 23-8, 42-1, 42-4, 42-5, 52-2, 52-5, and 52-6 were 42.0, 42.9, 37.8, 49.8, 42.5, 43.0, 40.7, and 44.1%, respec- the LPAT activities of several 6. napus transgenic plants were highly elevated, with 18:1-CoA:LPAT activity increased by two-to fivefold. 22:1-CoA:LPAT activity in these transgenic lines was markedly increased compared with the negligible activity present in developing seed of nontransformed controls.
LPAT Analyses of Arabidopsis and 6. napus SLC7-1 Transformants
Lipid Analyses of Arabidopsis SLC1-1 Transformants
Many Arabidopsis SLC1-1 transgenic T 2 seed lines (21 of 48) showed significantly increased oil content (an 11 to 49% increase in micrograms of total fatty acids per 50 or 100 seeds) compared with nontransformed controls and pBI121 or pRD400 transgenic controls (without the SLC1-1 insert, but with a kanamycin resistance gene as a selectable marker). Table 3 shows data for several of the Arabidopsis SLC1-1 T 2 generation seed lines that, in addition to increased oil content, also exhibited significant increases in total VLCFA content, especially eicosenoic (20:1) and erucic acids (22:1), as well as increased overall proportions of VLCFAs. The processes of transformation and kanamycin selection alone had no significant effect on seed oil content or fatty acid composition, because these values were not significantly tively. However, given the small size and weight of samples of even substantial numbers of transgenic seeds of Arabidopsis and the fact that the number of siliques and seeds per plant is not significantly affected, we believe it more accurate to express the data on the basis of analyzing 50 to 100 seed samples carefully counted under a dissecting microscope. The availability of more transformed seed and fewer lines to analyze allowed replicates of the larger 100-seed sample size to be analyzed in the T3 generation. In addition to increases in oil content, T, seeds from severa1 SLC7-7 transformants exhibited increases in the amounts of VLCFAs (micrograms per 100 seeds) and levels of VLCFAcontaining c 5 6 to c 6 0 TAGs, as shown in Table 4 . Thus, the traits of eíevated oil and VLCFA contents originally obtained in the segregating T, generation were heritable. As shown in Table 5 , stereospecific analyses of T3 seed
TAGs from selected independent SLC7-7 lines contained increased proportions of VLCFAs (e.g., eicosenoic acid, 20:l) at the sn-2 position. This trend was consistent, regardless of whether the data were expressed as the proportion of total 20:l found at the sn-2 position in TAGs (Table 5, footnote b) or as the proportion, among all sn-2 position fatty acids in TAGs, which is represented by 20:l (Table 5 , footnote c).
Furthermore, the increase in proportions of VLCFAs (e.g., eicosenoic acid) at the sn-2 position of TAGs was generally correlated with a decrease in the proportions of CI8 polyunsaturated fatty acids at this position. After propagating these selected Arabidopsis T3 seed lines, analyses of the T3 plantlets indicated that leaf fatty acid content (on a dry weight basis) and composition were not significantly different from that observed in leaves of pB1121 control transformants and in nontransformed wild-type plants.
Lipid Analyses of B. napus cv Hero SLC7-1 Transformants Severa1 6. n. Hero SLC7-7 T2 transgenic seed lines exhibited significantly increased erucic acid content, as shown in Table 6 . The overall proportions of VLCFAs, including erucic acid, were also increased in most of these seed lines. The proportions of 22:l in SLC7-7 transgenic seeds ranged from 49.1 to 56.2 weight %, compared with 45.2 2 0.5 weight % for nontransformed controls. Analyses of TAG classes by gas chromatography showed that Hero SLC7-7 transformant lines had increased proportions of c62 to c 6 6 TAGs (containing two or more C , , fatty acids), primarily at the expense of TAGs containing two (C56) or three (C53 C,8 fatty acids (data not shown). In the SLC7-7 Hero transgenic lines, the proportions of (& to CE TAGs ranged from 47.2 to 59.6 mol%, compared with nontransformed Hero, where the c 6 2 to & TAGs constituted 38.1 5 1.5 mol% (n = 9). The proportion of c 6 6 TAGs increased from 0.1 O mol% in nontransformed controls to 0.25 to 0.40 mol% in several SLC7-7 lines (including lines 5-4, 8-4, and 8-6) .
Lipase-based stereospecific analyses of TAGs isolated from several SLC7-7 transformants showed small increases in the proportions of erucic acid and total VLCFAs at the sn-2 position. In general, these sn-2 increases were correlated with increases in overall proportions of erucic acid or VLCFAs in the seed oil. For example, in the seed oil of SLC7-7 transgenic lines 3-1 and 8-6, the sn-2 erucic proportions were 4.1 and 3.5 weight %, respectively, and the respective total proportions of erucic acid were 56.2 and 50.5 weight %, whereas in nontransformed seed, erucic acid typically constituted <1 weight % of the sn-2 fatty acids, and the total proportion of erucic acid in TAGs was -45 weight %. The finding of negligible levels of erucic acid at the sn-2 position in nontransformed Hero is consistent with our previous work with this cultivar .
The oil content of severa1 SLC7-7 transgenic lines (expressed on a dry weight basis) was elevated by 8 to 22% over that observed in the nontransformed controls (Table 6) . Values for oil content in the SLC7-7 transgenics were consistently higher than were those in the nontransformed controls, whether the data were expressed on the basis of percentage of dry weight or micrograms of total fatty acids per seed. Furthermore, estimates of relative oil content by a nondestructive H-nuclear magnetic resonance (I H-NMR) method generally correlated with measurements made by a destructive (transmethylation-based) method (Table 6 ). The one exception to this general trend was line 3-1, which had an oil content comparable to the controls but the highest proportions of erucic acid and VLCFAs.
As 1.7 weight % and 0.6 ? 0.2 weight %, respectively, whereas the corresponding values for the average of seven independent T, lines (3-1, 7-3, 7-6, 7-9, 8-4, 8-6 , and 8-10) were 17.0 2 0.6 weight % (1 6:O) and 1.5 2 0.3 weight % (24:O).
DISCUSSION
We have provided strong evidence that the yeast SLC gene products encode enzymes that possess sn-2 acyltransferase activity and can exhibit LPAT activity in vitro. The expression of multiple copies of the SLC7 or SLC7-7 genes in the SLC deletion mutant resulted in a 2.5-to threefold increase in 18:l -CoA:LPAT activity after galactose induction, compared with the activity indigenous to the YMN5 strain (Table 1) . Furthermore, both the SLC7 and SLC7-7 gene products were able to use a range of CI8 to C2, acyl-CoAs when LPA was supplied as the acyl acceptor. The capacity to use 22:l-COA or 24:O-COA in the LPAT reaction was unique to the SLC transformants and was not found in the YEpUra3 (without SLC insert) transformant or in the nontransformed YMN5 deletion mutant. Taken together, the yeast expression data indicate that both SLC genes encode sn-2 acyltransferases capable of performing the LPAT reaction, using a broad range of acyl-COA donors. The fact that 22:l -COA and 24:O-CoA:LPAT activities were observed only in the SLC transformants indicates that these genes actually encode sn-2 acyltransferases and minimizes the possibility that they encode regulatory proteins. Compared with the SLC7 gene product, the single base change of nucleotide 131 from an A to a T residue, which results in an amino acid change at position 44 from glutamine to leucine, gives the SLC7-7 gene product an improved capacity to utilize verylong-chain acyl-CoAs in an LPAT reaction. The SLC deletion mutant YMN5 (Nagiec et al., 1993) was found to possess a low leve1 of sn-2 acyltransferase activity. The known mechanism(s) for de novo synthesis of membrane phospholipids in yeast, and indeed all eukaryotes, necessarily involves an acylation of the sn-2 position of LPA to give PA (Carman and Zeimetz, 1996) . One might expect that the inability to perform such a reaction would prove lethal. Because the SLC deletion mutant was viable without a functional SLC gene, the presence of another gene product capable of acylating the sn-2 position of LPA was therefore expected.
Thus far, we have no evidence that the SLC genes express sn-2 acyltransferase activity other than LPAT. The increased proportions of 26:O found at the sn-2 position of novel Pls in the SLC7-7 mutant, as reported in a previous study by Nagiec et al. (1993) , are probably the result of the SLC7-7 LPAT's capacity to incorporate very-long-chain saturated fatty acids into the sn-2 position of PA. PA could then be converted to cytidine diphosphate-diacylglycerol (CDP-DAG) and then to PI, via the enzymes CDP-DAG synthase and PI synthase, respectively (Carman and Zeimetz, 1996) . Because the SLC7-7 gene product exhibits LPAT activity and is capable of using a range of acyl-CoAs, we decided to test its effect when expressed in oilseed plants containing varying levels of VLCFAs in their seed oils. The expression of a yeast SLC7-7 sn-2 acyltransferase in both Arabidopsis and 6. napus resulted in dramatic increases in seed oil content and changes in seed oil composition.
____
The higher levels of LPAT activity exhibited in developing seed of the SLC7-7 transgenic plants correlate well with the yeast expression data and provide additional evidence that the gene does indeed encode a variant sn-2 acyltransferase that is capable of utilizing LPA as an acceptor. The fact that developing seed of the B. napus cv Hero transgenic plants contained significant levels of 22:l -CoA:LPAT activity, whereas the nontransformed control was essentially devoid of this activity (see Table 2 ), further confirms that the SLCI-7 gene encodes an acyltransferase with an altered specificity compared with the native plant gene.
Because the yeast sn-2 acyltransferase is able to accept a wide range of acyl-CoAs as substrate, it is perhaps not surprising that the seeds of SLC7-7 transgenic plants were shown to contain oils with increased proportions of VLCFAs at the sn-2 position. Similar and even more dramatic results have been reported in experiments in which meadowfoam (Limnanthes spp) LPAT transgenes were expressed in 6. napus (Lassner et al., 1995; Brough et al., 1996) , resulting in elevated sn-2 proportions of erucic or lauric acid, respectively. However, to our knowledge, the current sn-2 acyltransferase transgenic experiments are novel in that they result in increased overall proportions or amounts of VLCFAs in seed oils. The best Arabidopsis and 6. napus transformant lines exhibited increases in proportions of seed VLCFAs of 6 and 20 weight %, respectively. Hero transgenic line 3-1 had in excess of 56 weight YO erucic acid and almost. 80 weight % total VLCFAs in T2 seed oil, which to our knowledge is the highest proportion of VLCFAs achieved in B. napus to date.
Of even greater significance, however, is the fact that the expression of the yeast sn-2 acyltransferase resulted in increased seed oil content in many transgenic plants. Until now, increases in seed oil content of this magnitude by plant transformation have not been reported. This effect was consistent, regardless of how the data were expressed. Indeed, noninvasive 'H-NMR estimates of increased oil content in B. napus cv Hero SLC7-7 transgenic plants were also generally correlated with increased seed weights in many of the transgenics (increases of 9 to 38%) and suggested that the increased seed dry weights were at least partially attributable to increased oil, with negligible contribution from seed water (absence of broad water resonance between the CH,OCOand CHOCO-chemical shifts; Rutar, 1989) . Seed weight increases of 10 to 80% were also observed in many of the Arabidopsis transgenic plants. The one exception to the general trend of increased oil content and seed weight was line 3-1; the total oil content in this line (33.5% dry weight) was not significantly different than it was in seeds of the Hero controls (Table 6 ), but seed weight was decreased by up to 40%. As cited above, this line also had the highest proportion of VLCFAs (-80%). It is possible that the accumulation of very high proportions of seed VLCFAs can affect seed developmentkize so that oil deposition (and perhaps other processes) is somewhat inhibited. Although data on such effects have not been documented, it is interesting that transgenic B. napus containing a meadowfoam LPAT resulted in significant increases in seed oil sn-2 erucic acid but that there were no reports of seeds with increased oil content or higher total proportions of erucic acid; average seed weights and plant vigor were not addressed (Lassner et al., 1995; Brough et al., 1996) .
In transgenic Arabidopsis and €3. napus cv Hero seeds, 60 to 75% of the increase in oil content could be accounted for by increases in the proportions and absolute amounts of VLCFAs, particularly the respective increases in eicosenoic and erucic acids. Twenty-five to 40% of the increment could be accounted for by the substantial increases in the accumulation of other non-VLCFAs, such as palmitate, oleate, linoleate, and linolenate. This suggests that it is reasonable to predict that similar increases in oil content or improvements in composition could be achieved in oilseed crops that do not accumulate appreciable VLCFAs, such as canola-quality B. napus, soybean, sunflower, flax, maize, and cotton.
It is known that some metabolic pathways are controlled at multiple levels. The regulation is spread over several steps, and the cumulative contributions determine the overall flux through the metabolic process (Ohlrogge and Browse, 1995) . Thus far, regulation of the Kennedy pathway in developing oilseeds has been poorly understood. Our results, obtained in a plant transformation approach using a heterologous yeast acyltransferase, suggest that the reactions catalyzed by sn-2 acyltransferases (e.g., LPAT) may constitute one of the regulatoty steps in the biosynthesis of TAGs in developing oilseeds.
In previous experiments in which meadowfoam or coconut LPAT genes were expressed in B. napus, no increase in overall oil content was reported (Lassner et al., 1995; Brough et al., 1996) . However, such results do not exclude and indeed may suggest the possibility that plant LPATs are tightly controlled in vivo. The regulation of enzyme activity could be achieved at several levels. For example, mammalian acylCoA:cholesterol acyltransferase activity is primarily controlled by protein phosphorylation (Gavey et al., 1983) . A possible reason for the significant increase in oil content in the SLC7-7 transgenic Brassicaceae may be the result of differences in sn-2 acyltransferase regulation. The overall homology between the yeast sn-2 acyltransferase and the plant sn-2 acyltransferases from meadowfoam and coconut (Brown et al., 1995; Knutzon et al., 1995; Lassner et al., 1995) is only 24% and is restricted mainly to the C termini of the proteins. Indeed, there was no cross-hybridization of a labeled SLC7-7 probe with RNA isolated from nontransformed Arabidopsis (see Figure 1) or B. napus seeds at middevelopment, and'it was not possible to isolate plant LPATs by using the SLC7-7 gene as a probe (J.-T. Zou, V. Katavic, and D.C.
Taylor, unpublished result). In contrast, the meadowfoam and coconut acyltransferases have much greater overall homol-ogy to each other (62% amino acid identity), and regions of homology extend throughout these sequences. It may be that the yeast SLC7-7 transgene is not as tightly regulated as are plant LPAT transgenes. In this context, it is interesting that both the meadowfoam and coconut LPAT sequences possess putative tyrosine phosphorylation sites. The characteristic motif consisting of an arginine at position -7, tyrosine at position O, and glycine at position +5 (Cooper et al., 1984 ) is present at amino acids 68 (arginine), 75 (tyrosine), and 80 (glycine), respectively, in the meadowfoam sequence (Brown et al., 1995; Lassner et al., 1995) and at amino acids 89 (arginine), 96 (tyrosine), and 1 O1 (glycine), respectively, in the coconut sequence (Knutzon et al., 1995) . However, this motif is absent in the yeast SLC7-7 gene. Thus, although further concrete experimental evidence is needed, the increased oil content after SLC7-7 expression may be the result of unregulated sn-2 acyltransferase activity, creating a new sink for lipid deposition. The channeling of more fatty acids into PA, via increased LPAT activity, could result in a larger flux through the Kennedy pathway from PA to DAG and ultimately to TAG. Our results also imply that fatty acid biosynthesis is capable of keeping up with substantial increases in demand from the expanded sink capacity.
Analogous results were obtained in attempts to alter the deposition of starch in plant tissues (Stark et al., 1992) . By expression of a mutant E. coli glgC76 gene encoding an ADP-glucose pyrophosphorylase in potato tubers, an increase in starch accumulation was achieved. The increase was observed only by using the mutated form of the gene (encoding an ADP-glucose pyrophosphorylase enzyme with a single substitution of aspartate for glycine at position 336), and this result was attributed to reduced interference by the complex allosteric regulation of the wild-type E. coli gene.
However, given its overall effect on increases in seed weight, only part of which can be accounted for by increased oil content, it is perhaps too simplistic to attribute the overall effects of the yeast transgene solely to increased LPAT activity. It is equally plausible to speculate that in addition to its role as an sn-2 acyltransferase, the expression of SLC7-7 in the developing seed might result in a perturbation of steady state levels of diacylglycerol, PC, or inositol phospholipids, which may trigger signal transduction mechanisms involved in cell growth and differentiation during embryogenesis. The SLC7-7 gene product has a relatively loose substrate specificity and therefore could also function as a "scavenger sn-2 acyltransferase enzyme," which could channel various sn-1 acyl-glycerophospholipids into the diacylglycerol pool and then into TAG.
Whereas the presence of the SLC7-7 gene resulted in increased TAG content in many transgenic plants, the extent Figure l) , the augmented LPAT activity measured in vitro was highest in line 42-5 (cf. Table 2 ). In comparing three B. napus cv Hero SLC7-7 transgenic lines (3-1, 7-6, and 8-6), the highest augmented LPAT activity measured in vitro was in lhe 3-1 (cf. Table 2 ), yet it was line 8-6 that exhibited the highest increase in oil content (cf. Table 6 ); rather unexpectedly, there was no oil content increase in line 3-1. Such differences in levels of transcript or activity of gene product among independent transgenic events are not uncommon. These results suggest that expression of even small amounts of the SLC7-7 gene may be sufficient to overcome limitations in PA levels during TAG biosynthesis. It is also possible that in vivo, the supply of LPA or acyl-CoAs may become rate limiting, causing variations in the actual level of TAG accumulating in each transgenic seed. In contrast, in vitro assays of LPAT activity are performed with cell-free extracts and in the presence of probable excesses of both LPA and acyl-COA substrates. The use of the yeast SLC7-7 gene to achieve the effects described herein may also present an opportunity to further improve seed oil composition and content in a way not possible when the initial transformation is performed with a plant acyltransferase. In effect, the limited homology between plant LPATs and the yeast sn-2 acyltransferase is low enough to allow strategies to downregulate the host plant LPAT by conventional means (e.g., antisense RNA technology or a cosuppression phenomenon; MOI et al., 1990; Van Blokland et al., 1993; De Lange et al., 1995) without a concomitant negative impact on the expression of the yeast transgene or 09 plant seed development. Thus, the yeast transgene strategy has a distinct advantage over that in which another plant transgene is introduced into a host plant in which there is a highly homologous, indigenous seed LPAT.
Although the yeast acyltransferase was expressed under the control of a constitutive (tandem 35s) promoter in the current experiments, there were no significant effects on fatty acid content or composition in the vegetative portions of the transgenic plants. Because the SLC7-7 transcript levels were generally stronger in leaves of the transgenic plants than in seeds, these results suggest that the pools of available LPA and/or acyl-CoAs may be more tightly regulated in leaves (source) that accumulate little TAG compared with the cotyledons of developing seeds constituting a strong storage lipid sink. Although it is tempting, given the demonstrated capacity of the SLC7-7 acyltransferase to utilize very-long-chain saturated fatty acyl-CoAs, it is difficult to assign a high level of significance to the doubling in proportions of 24:O observed in leaves of the Hero transgenic plants. The wild-type 24:O proportion is very small (0.6 weight %), and the selection of rapidly expanding leaves is difficult to normalize. In summary, the current study demonstrates that the yeast SLC7-7 gene encodes an sn-2 acyltransferase, which, when expressed in plants, is capable of significantly increasing seed oil content, altering the fatty acid composition of seed TAGs, and increasing LPAT activity in the developing seed. Such findings strongly suggest that in developing oilseed embryos, plant sn-2 acyltransferases may be tightly regulated, playing some larger role in controlling the overall flux of acyl moieties through the Kennedy pathway. Recently, we also obtained similar increases in oil content and VLCFA proportions in T2 seeds of transgenic 6. napus cv Reston, and in a B. carinata breeding line C90-1163 (both are high erucic acid Brassica spp), after transformation with the SLC7-7 gene under the control of the tandem 35s promoter. In Reston, the oil content in seed from four SLC7-7 transgenic lines was increased by 21 to 26% compared with the nontransformed control, and proportions of erucic acid increased from 34.7 weight % in nontransformed controls to 37.4 and 41.1 weight % in the two best transgenic lines. B.
carinata seed oil content in two transgenic lines increased by 11 and 19% compared with nontransformed controls, whereas erucic acid proportions rose from -42 weight % in nontransformed B. carinata to 50 weight % in the best transgenic line. Clearly, the results obtained thus far are similar in a wide variety of Brassica spp.
We conclude that the increases in overall proportions and amounts of VLCFAs in the SLC7-7 transgenic Brassica seeds are probably the cumulative result of an increased flux of fatty acids through the Kennedy pathway, combined with a significantly improved capacity to incorporate VLCFAs into the sn-2 position. Admittedly, although the relative specificity of the yeast sn-2 acyltransferase for erucoyl-COA versus oleoyl-COA measured in vitro is apparently lower than that of the LPAT from developing meadowfoam seeds (Taylor et al., 1993; Lassner et al., 1995; Brough et al., 1996) , the overall effects of the yeast transgene appear superior. In a previous study (Katavic et al., 1995) , we demonstrated that an Arabidopsis mutant exhibiting decreased diacylglycerol acyltransferase activity accumulated less TAG and synthesized much reduced proportions and amounts of VLCFAs, particularly 20:l. Clearly, the assembly of TAGs and the flux of VLCFAs into Kennedy pathway intermediates can have a profound effect on the levels of VLCFAs synthesized by elongation. Studies with Arabidopsis have shown that in the elongase complex, the level of the fatty acid elongation (FAE7) gene product for the condensing enzyme is rate limiting to the accumulation of VLCFAs (Kunst et al., 1992; Millar and Kunst, 1997) . Thus, it would be interesting to attempt to boost the level of VLCFAs in Arabidopsis or 6. napus by combining the FAE7 and SLC7-7 transgene effects. New information concerning factors that may limit VLCFA accumulation may come from additional analyses of B. napus cv Hero SLC7-7 lines 3-1 versus 8-6 or other transgenic 6. napus plants containing the meadowfoam LPAT gene.
There are other important issues to be addressed beyond the scope of the current study. For example, the effects (both quantitative and qualitative) of SLC7-7 expression on other seed components, such as storage proteins, oleosins, minor lipid constituents, phytate, and glusosinolates, need to be examined. Utilizing these transgenic oilseed lines, it is now possible to develop homozygous lines and thereby investigate the relative importance of the sn-2 acyltransferase transcript and protein levels on increased TAG synthesis and changes in acyl composition as well as its effects on many of these other important seed components.
Because the Kennedy pathway is common to all oilseeds, it is reasonable to assume that the effect of the SLC1-7 transgene on oil content will be generic. Accordingly, additional experiments are in progress to express the SLC7-7
gene under the control of seed-specific promoters and in a variety of other oilseed crops. It is hoped that these transgenic plants will exhibit equally dramatic increases in oil content and changed lipid composition.
METHODS
General Molecular Biology Techniques
Unless stated otherwise, all molecular biological techniques (polymerase chain reaction [PCR] , DNA and RNA gel blot analyses, plasmid preparations, and restriction digestion) were performed by methods generally prescribed by Sambrook et al. (1989) or Ausubel et al. (1 995) .
Construction of the SLCI-I Vector for Plant Transformation
The DNA and amino acid sequences for the coding region of the SLC7-7 gene have GenBank, EMBL, and DDBJ accession number L13282. Plasmid p411AB/C (kindly provided by R.C. Dickson; Nagiec et al., 1993) harboring the suppressor allele of the SLC gene (SLC1-1) was used as a template in a PCR with two primers, OM087 and OM088. Primer OM087 (5'-AGAGAGAGGGATCCATGAGTGTGATAG-GTAGG-3') and primer OM088 (5'-GAGGAAGAAGGATCCGGGTC-TATATACTACTCT-3') have 5' BamHl restriction site extensions and were designed according to the 5' and 3' end sequences, respectively, of the SLC7 gene. This reaction yielded an SLC7-7 PCR fragment with a BamHl site at both ends. The SLC1-7 PCR fragment therefore represents the suppressor allele of the SLC7 gene, with nucleotide T substituting for nucleotide A at position 131, resulting in an amino acid residue change from glutamine to leucine at residue 44. The fragment was digested with BamHl and ligated into the BamHl cloning site located between the tandem cauliflower mosaic virus 35s promoter and nopaline synthase terminator in vector pB1524 (obtained from R. Datla, National Research Council of Canada, Plant Biotechnology Institute, as described by Datla et al. [1993] ) to give vector SLC7-7-pB1524. The orientation of SLC7-7 in the vector SLC7-7-pB1524 was verified by restriction digestion with Bg111, which cuts SLC7-7 at nucleotide 377 from the 5' end and immediately downstream of the tandem 35s promoter in vector pB1524. The translation initiation codon of SLC7-7 is maintained, and hence the construct is a transcriptional fusion. The Hindlll and EcoRl fragment containing a tandem 35s promoter, alfalfa mosaic virus enhancer, SLC7-7 coding sequence, and nopaline synthase terminator was freed from SLC7-7-pB1524 and cloned into the EcoRI-Hindlll site of vector pRD400 (also obtained from R. Datla et al., 1992) . The final vector pSLC7-llpRD400 was introduced into Agrobacterium tumefaciens GV3101 (bearing helper plasmid pMP9O; Koncz and Schell, 1986) by electroporation.
Construction of SLCI-I and SLCI Multicopy Vectors and Transformation of Yeast SLC Deletion Strain Genomic DNA of Saccharomyces cerevisiae was used as a template to amplify the coding region ofSLC7 with two primers, OM089 (S-TGA-ATTCGGATCCGTTAACAATGAGTGTGATAGG-3') and OM088 (described above). The coding regions of the PCR-amplified allelesSLC7 and SLC7-7 (described previously) were confirmed by sequencing and demonstrated that the expected point mutation (a T at nucleotide 131) exists in SLC7-7. The PCR fragments were digested with BamHl and cloned into the corresponding site in vector pYEUra3 (Clontech, Palo Alto, CA). The orientation of the inserts was checked using Xbal and Bglll double digestion. Constructs with SLC transcription under the control of the GAL7 promoter released a fragment of ~6 0 0 bp. Because both SLCl and SLC7-7 fragments have their own initiating ATG codons, the products expressed are not fusion proteins.
An SLC deletion strain (YMN5; s/c7A2::LEU2 ura3) was kindly provided by M.M. Nagiec and R.C. Dickson (Nagiec et al., 1993) . Yeast transformation was performed according to Elble (1992) . Nontransformed YMN5 (SLC deletion mutant) cells and transformants containing only vector were used as controls. Single colonies were cultured overnight in 20 mL of SD medium (synthetic dextrose medium with glucose and without uracil, as described by Ausubel et al. [1995] ) on a rotary shaker (270 rpm) at 28°C. Cells were pelleted from the overnight culture and resuspended in 50 mL of either SD medium containing glucose and without uracil (noninduction medium) or medium for induction of expression (SD medium containing galactose and without uracil). Cells were reincubated at 28"C, with shaking at 270 rpm, and they were harvested after 6 or 24 hr.
Plant Material and Growth Conditions
Arabidopsis thdiana ecotype Columbia was obtained originally from G. Haughn (University of Saskatchewan, Saskatoon, Canada). Brassica napus cvs Hero (Scarth et al., 1991) and Reston were obtained from the Plant Science Department of the University of Manitoba (winnipeg, Canada). E. carinata breeding line C90-1163 was obtained courtesy of G. Rakow (Agriculture and Agri-Food Canada Research Centre, Saskatoon).
All Arabidopsis control and transgenic plants were grown at the same time in controlled growth chambers, under continuous fluorescent illumination (150 to 200 kE m-2 sec-l) at 22"C, as described by Katavic et al. (1995 Agrobacterium bearing theSLC7-7/RD400 construct was used to transform Arabidopsis by wound inoculation or vacuum infiltration methods. In high erucic acid B. napus cv Hero and Reston and ifl B. carinata breeding line C90-1163, transformation was by cocultivation of cotyledonaty petioles and hypocotyl explants.
Wild-type Arabidopsis ecotype Columbia plants were grown in soil. Transformation was performed by wound inoculation (Katavic et al., 1994) or vacuum infiltration (Bechtold et al., 1993 ) with a bacterial suspension (which had been cultured overnight) of Agrobacterium strain GV31 O1 bearing helper nopaline synthase plasmid pMP9O (disarmed Ti plasmid with intact vir region acting in trans with gentamycin and rifampicin selection markers; Koncz and ScheIl, ) and binary vector pSLC7-7lpRD400 containing a kanamycin selection marker. After inoculation or infiltration, plants were grown to set seeds (T,) . Mature T, seeds were harvested in bulk and screened on selective medium with 50 mglL kanamycin. After 2 to 3 weeks on selective medium, seedlings were transferred to soil. Leaf DNA was isolated from kanamycin-resistant T1 plants and analyzed by PCR amplification of the SLC7-7 fragment. Developing leaves from TI plants as well as mature T2 seeds were used for lipid and biochemical analyses. Developing leaves and mature seeds from nontransformed wild-type Columbia plants and from plants transformed with either pB1121 (binary vector pB1121 containing the kanamycin selection marker and the p-glucuronidase reporter gene; Jefferson et al., 1987) or pRD400 (containing the kanamycin selection marker; Datla et al., 1992) , both without the SLC1-7 insert, were used as controls in analyses of seed lipids. Based on these analyses, T, seeds of lines exhibiting changed acyl composition and/or lipid content were grown on selective medium (to eliminate homozygous wild-type segregants) and then transferred to soil to yield T3 seeds.
Transformation experiments performed with B. napus cv Hero, using Agrobacterium bearing the SLC7-7/RD400 construct, utilized hypocotyl explants and a modified method of DeBlock et al. (1989) . To optimize transformation conditions, modifications of the hypocotylexplant transformation method (DeBlock et al., 1989) included (1) preculture of explants on agar-solidified Murashige and Skoog (MS) medium (Murashige and Skoog, 1962) with the growth regulators 2,4-D and kinetin; (2) cocultivation of hypocotyl explants with Agrobacterium in Petri dishes on sterile filter paper with the same medium as that used for preculture; (3) after cocultivation, a 7-day explant recovery period on medium with 2,4-D and kinetin, and with timentin for Agrobacterium elimination; (4) regeneration of transgenic shoots on MS medium with the cytokinins benzyladenine and zeatin, the ethylene inhibitor silver nitrate, and the antibiotics timentin (for Agrobacterium elimination) and kanamycin (for transformed-cell and shoot selection). For transformation of B. napus cv Reston and B. carinata plants, cotyledonary petiole explants were used, and the method of Moloney et al. (1989) was modified to include the introduction of a 7-day explant recovery period after cocultivation on MS medium supplemented with benzyladenine and timentin.
Green shoots were rooted and transferred to soil. Genomic DNA was isolated from developing leaves, and PCR and gel blot analyses (Southern, 1975) were performed. Seeds (T,) from transgenic plants were harvested, and from each transgenic line, 10 T, plants were 1 -14C-labeled 18:1, 22:1, and 24:O free fatty acids (50 to 55 mCi/ mmol) were purchased from Amersham Canada (Oakville, Ontario), Du Pont Canada (Mississauga, Ontario), and American Radiolabeled Chemicals (3. Louis, MO), respectively. 1 -14C-labeled 203 was synthesized as described previously . 1 -14C-labeled acyl-COA thioesters were then synthesized by the method of Taylor et al. (1990) . sn-1-18:l-lysophosphatidic acid (18:1-LPA), sn-1-18:Ilysophosphatidylcholine (1 8:l -LPC), sn-l-18:I -lysophosphatidylethanolamine (1 8:l -LPE), sn-I-acyl lysophosphatidylinositol (LPI), COA, ATP, and all other biochemicals were purchased from Sigma. Silica G and silica H were purchased from Merck (Darmstadt, Germany). All solvents were of HPLC grade or better and were purchased from BDH (Toronto, Ontario).
Lipid Analyses
Mature seeds were harvested from SLC7-7 transgenic plants, nontransformed wild-type control plants, or control transgenic plants transformed with pB1121 or pRD400 without the SLC7-7 insert. For leaf lipid assays, leaves at midexpansion were chosen from control and transgenic plants. In the Arabidopsis leaf analyses, two to three whole leaves were utilized, whereas in the case of 6. napus transformants, I-cm-diameter leaf discs were sampled from severa1 leaves and pooled. In the case of Arabidopsis plants, because of the extremely small seed size and weight, analyses were performed on 50-or 100-seed replicates that were carefully counted under a djssecting microscope. When dry weights per sample were required, 400-seed equivalents were counted and weighed, and the values were used to calculate the equivalent lipid content for a 100-seed sample. Seed samples were ground using a polytron in chloroform-isopropano1 (2:l [VIVI) containing 0.2% (w/v) butylated hydroxytoluene and tripentadecanoin as an interna1 standard. All other conditions for the isolation and gas chromatography analyses of seed and leaf lipids for total fatty acid content and fatty acid composition (expressed as weight % of total fatty acids) were as described previously (Taylor et al., , 1995b Katavic et al., 1995) . Triacylglycerol (TAG) species were analyzed by high-temperature gas chromatography, as described by Katavic et al. (1995) , and stereospecific analyses of TAGs were performed using pancreatic lipase on intact seed lipids (chiefly TAGs), as described by Christie (1982) .
sn-2 Acyltransferase Assays
Cells of yeast transformants and control cultures (induced with galactose) and noninduced cultures (with glucose) were harvested by centrifugation at 5000 rpm for 5 min and resuspended in 100 mM Hepes-NaOH, pH 7.4, containing 1 mM EDTA and 1 mM DTT. Gell lysates were prepared using acid-washed glass beads as described by Ausubel et al. (1995) , and assays of lysophosphatidic acid acyltransferase (LPAT) activity in lysate protein (30 to 50 kg) were conducted using the protocols described below.
For Arabidopsis, 25 to 30 siliques were harvested at 15 to 18 days postanthesis to isolate midcotyledonary T3 embryos from both controls (the nontransformed wild type and the pB1121 control transformant) and selected transgenic plants. E. napus T2 embryos at the midcotyledonary stage of development were harvested from three to six siliques of nontransformed control and selected transgenic plants. All plant material was frozen immediately in liquid nitrogen and stored at -70°C until homogenized. Homogenates of developing seed tissues were prepared as described by Taylor et al. (1 995b) .
LPAT assays were conducted at pH 7.4, with shaking at 1 O0 rpm in a water bath at 30°C for 15 to 30 min. Assay mixtures (0.5 mL final volume) contained homogenate or lysate protein (10 to 200 pg), 90mM Hepes-NaOH, 0.5 mM ATP, 0.5 mM COA, 1 mM MgC12, 45 pM sn-l-oleoyl-LPA, and 18 pM 1 -14C-labeled 18:l -COA, 1 -1 4 C labeled 20:l -COA, 1 -i4C-labeled 22:l -COA, or 1 -i4C-labeled 24:O-COA (each at a specific activity of 10 nCi/nmol) as the acyl donor. Control reactions were conducted in the absence of protein and in the absence of an exogenous acyl acceptor. All other conditions for the measurement of LPAT activity were as detailed previously (Taylor et al., 1995b) . Protein in yeast lysates or seed homogenates was measured using the Bradford (1976) assay.
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